7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,556.48

+1,073.97

+1.40%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

LSE - Delayed Quote GBp

Shield Therapeutics plc (STX.L)

5.65 +0.15 (+2.73%)

At close: October 30 at 4:08:40 PM GMT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris

Proactive 2mo ago

STX.L
+2.73%
VTRS

SHIEF
Shield Therapeutics jumps 11% as losses narrow and profitability target held

Proactive 2mo ago

STX.L
+2.73%
STX

SHIEF
Shield Therapeutics plc's (LON:STX) Path To Profitability

Simply Wall St. 4mo ago

STX.L
+2.73%
Shield Therapeutics drops as CFO exits and Medicaid concerns weigh

Proactive 5mo ago

STX.L
+2.73%
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty

PR Newswire 3mo ago

6576.TWO

STX.L
+2.73%
VERU
ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel

Insider Monkey 5mo ago

PROK

STX.L
+2.73%

Performance Overview

Return	STX.L	FTSE 100 (^FTSE)
YTD	-42.64%	+8.04%
1-Year	-16.91%	+9.94%
3-Year	-10.32%	+46.43%

Mobilize your Website

View Site in Mobile | Classic

Share by: